RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluation.
暂无分享,去创建一个
K. Luk | A. Railkar | B. Higgins | K. Kolinsky | Yingsi Chen | T. Nevins | M. Simcox | Hong Yang | S. Kolis | Navita L. Mallalieu | L. Mcdermott | Melissa Smith | J. K. Li | June Ke | Tom Egan | Louise Gerber